Similar articles

• BCG vaccination of children against leprosy: seven-year findings of the controlled WHO trial in Burma.

  Bechelli LM, Garbajosa PG, Gyi MM, Uemura K, Sundaresan T, Martínez Domínguez V, Matejka M, Tamondong C, Quagliato R, Engler V, Altmann M. Bechelli LM, et al. Bull World Health Organ. 1973;48(3):323-34. Bull World Health Organ. 1973. PMID: 4270384 Free PMC article. Clinical Trial.
• BCG vaccination of children against leprosy: nine-year findings of the controlled WHO trial in Burma.

  Bechelli LM, Lwin K, Gallego Garbajosa P, Mg-Mg-Gyi, Uemura K, Sundaresan T, Tamondong C, Matejka M, Sansarricq H, Walter J. Bechelli LM, et al. Bull World Health Organ. 1974;51(1):93-9. Bull World Health Organ. 1974. PMID: 4281729 Free PMC article. Clinical Trial.
• BCG vaccination of children against leprosy: fourteen-year findings of the trial in Burma.

  Lwin K, Sundaresan T, Gyi MM, Bechelli LM, Tamondong C, Garbajosa PG, Sansarricq H, Noordeen SK. Lwin K, et al. Bull World Health Organ. 1985;63(6):1069-78. Bull World Health Organ. 1985. PMID: 2940028 Free PMC article. Clinical Trial.
• ILEP organisations should strive for high BCG coverage in communities at risk of leprosy.

  Velema JP, Ogbeiwi OI. Velema JP, et al. Lepr Rev. 2007 Jun;78(2):88-101. Lepr Rev. 2007. PMID: 17824479 Review.
• BCG vaccination in mycobacterial infections.

  Rees RJ. Rees RJ. Br Med Bull. 1969 May;25(2):183-8. doi: 10.1093/oxfordjournals.bmb.a070690. Br Med Bull. 1969. PMID: 4248333 Review. No abstract available.